What is the management plan for a patient with a high output ileocolostomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of High Output Ileocolostomy

Restrict hypotonic fluids to less than 1000 mL daily and replace remaining fluid requirements with isotonic glucose-saline solution containing at least 90 mmol/L sodium, while initiating antimotility medications and monitoring urine sodium to maintain levels above 20 mmol/L. 1, 2

Definition and Initial Assessment

High output is defined as 1000-2000 mL/24 hours, with outputs exceeding 2000 mL/24 hours placing patients at significant risk for dehydration, electrolyte depletion, and malnutrition. 1, 3

Key monitoring parameters include:

  • Daily stoma output measurement 2
  • Urine volume (target ≥800 mL/day) 3, 2
  • Random urine sodium (target >20 mmol/L) 1, 2
  • Serum electrolytes including sodium, potassium, magnesium, and renal function 1, 2
  • Body weight trends 3, 2

Acute Management Phase

For newly identified high output or acute decompensation:

  • Initiate intravenous normal saline (2-4 L/day) while keeping the patient nil by mouth to demonstrate that output is driven by oral intake 2
  • Gradually withdraw IV saline over 2-3 days while simultaneously reintroducing food and restricted oral fluids 2
  • Parenteral infusions (fluid and electrolytes) may be needed for ongoing high output stomas 1

Approximately 49% of early high-output stomas (within 3 weeks) resolve spontaneously, but 51% require ongoing medical treatment, particularly when remnant small bowel length is short. 1, 2

Fluid Management Strategy

The cornerstone of management is strategic fluid restriction and replacement:

  • Restrict hypotonic fluids (water, tea, coffee, fruit juices, alcohol) to less than 500-1000 mL daily, as these increase sodium losses through the stoma 1, 3, 2
  • Avoid hypertonic fluids (commercial soft drinks, concentrated fruit juices, cola) which also cause water and sodium loss 3, 2
  • Replace remaining fluid requirements with glucose-saline solution containing ≥90 mmol/L sodium (WHO cholera solution or St. Mark's solution), sipped throughout the day 1, 2

For patients with marginal high output (1-1.5 liters), oral fluid restriction (<1 liter/day) and addition of salt to the diet may be sufficient. 3

Pharmacological Management

Antimotility and antisecretory medications are essential:

  • Loperamide is first-line therapy, with doses of 12 mg/day shown to reduce ileostomy output by a median of 16.5% 4
  • High-dose loperamide should be considered in patients who fail conventional doses 5
  • Proton-pump inhibitors reduce gastric secretions that contribute to increased fecal losses 1
  • Additional agents include opium, psyllium fibers, and cholestyramine to reduce intestinal motility or secretions 1
  • Oral budesonide has been shown to improve water absorption and decrease stoma output in Crohn's disease patients with ileostomy 1

The large volume of gastric secretion minimizes time for absorption and contributes to increased fecal losses, making acid suppression particularly important. 1

Nutritional Considerations

Bulk-forming agents may slow gastric emptration and improve stool consistency and overall transit time in the small bowel 1

Assess and replace micronutrient deficiencies:

  • Vitamin B12 and iron deficiency with replacement therapy as needed 1
  • Consider assessment for selenium, zinc, and vitamins A, D, E, and K deficiencies 1

Malabsorption is an important contributing factor to malnutrition, and ongoing high output can result in intestinal insufficiency with unintentional weight loss and nutritional deficiencies. 1

Long-Term Management and Monitoring

Maintenance therapy continues as long as the stoma is present:

  • 71% of patients can be weaned from parenteral infusions using oral hypotonic fluid restriction, glucose-saline solution, and anti-diarrheal medication 1, 2
  • 8% require continued parenteral or subcutaneous saline in the home setting 1
  • Adjustments based on seasonal factors (increased losses in hot weather) 2

Early follow-up after discharge results in significant reduction in readmission rates and allows identification of patients with malnutrition. 1

Interdisciplinary Approach

Multidisciplinary intestinal rehabilitation is essential for successful management:

  • Stoma therapists or IBD specialist nurses should be involved as early as possible 1
  • Nutritional and clinical assessments must be performed on all patients with high-output stoma 1
  • Interdisciplinary team management is best when enterostomy becomes a cause of concern, particularly with nutritional issues 1

Common Pitfalls to Avoid

  • Do not allow unrestricted water intake, as hypotonic fluids paradoxically worsen sodium depletion and increase stoma output 1, 3, 2
  • Monitor urine sodium closely, as random urinary sodium <20 mmol/L suggests sodium depletion requiring intervention 1, 2
  • Avoid delaying parenteral support when oral measures are insufficient, as dehydration can culminate in acute renal failure 1
  • Do not underestimate the risk of dehydration, which necessitates hospital admission in up to 17% of patients after colorectal resection with diverting loop ileostomy 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fluid Management for Ileostomy Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

High Output Stoma Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.